PHIO News and Press, Phio Pharmaceuticals Corp. From 03/08/22

Phio Pharmaceuticals Announces Upcoming Presentation of PH-894 Data at the AACR Annual Meeting 2022 PR Newswire MARLBOROUGH, Mass. , March 8, 2022 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a clinical stage biotechnology company developing th...

Phio Pharmaceuticals Initiates In Vivo Studies of INTASYL Based Antivirals Against SARS-CoV-2 Advancement of additional studies is based on positive results from in vitro studies and the ongoing COVID-19 pandemic PR Newswire MARLBOROUGH, Mass. , Feb. 22, 2022 ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips We’re seeing major movement from some hot penny stocks today and are diving into what has them on the rise! Source: John Brueske/Shutterstock.com Before we get too far in. Just remember that penny stocks are ...

Phio Pharmaceuticals Announces Regulatory Clearance of Clinical Trial for PH-762 to Treat Melanoma <span class="legendSpanClass">French regulatory authorities grant Clinical Trial Authorization with dosing of first patient anticipated in the first quarter of 2022</span&...

Phio Pharmaceuticals Scheduled to Participate in the H.C. Wainwright Virtual BioConnect 2022 Conference PR Newswire MARLBOROUGH, Mass. , Jan. 3, 2022 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next gener...

Phio Pharmaceuticals Presents Positive New Data On Systemic Immune Response After Local PH-762 Therapy at the SITC 36th Annual Meeting PR Newswire MARLBOROUGH, Mass. , Nov. 12, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a biotechnology c...

Phio Pharmaceuticals (NASDAQ:PHIO): Q3 GAAP EPS of -$0.28 misses by $0.03. Cash Balance of $26.5M Press Release For further details see: Phio Pharmaceuticals EPS misses by $0.03

Phio Pharmaceuticals Reports Third Quarter 2021 Financial Results and Provides Business Update Lead program, PH-762, is on track to enter first-in-human clinical study in Q1 2022 Presented data at the ESMO Congress 2021 showing Dual-Targeting INTASYL PH-3861 induced a durabl...

Phio Pharmaceuticals Announces Upcoming Presentation at the SITC 36th Annual Meeting PR Newswire MARLBOROUGH, Mass. , Oct. 18, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology company developing the next generation of immuno-on...

Phio Pharmaceuticals Presents New BRD4 Data at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics PR Newswire MARLBOROUGH, Mass. , Oct. 7, 2021 /PRNewswire/ -- Phio Pharmaceuticals Corp. (Nasdaq: PHIO), a biotechnology compan...